TW257678B - - Google Patents

Info

Publication number
TW257678B
TW257678B TW082109442A TW82109442A TW257678B TW 257678 B TW257678 B TW 257678B TW 082109442 A TW082109442 A TW 082109442A TW 82109442 A TW82109442 A TW 82109442A TW 257678 B TW257678 B TW 257678B
Authority
TW
Taiwan
Prior art keywords
host
sulfated
acetylated
substances
substantially purified
Prior art date
Application number
TW082109442A
Other languages
English (en)
Original Assignee
Yedares And Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yedares And Dev Co Ltd filed Critical Yedares And Dev Co Ltd
Application granted granted Critical
Publication of TW257678B publication Critical patent/TW257678B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
TW082109442A 1992-11-10 1993-11-10 TW257678B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97475092A 1992-11-10 1992-11-10
US9673993A 1993-07-23 1993-07-23

Publications (1)

Publication Number Publication Date
TW257678B true TW257678B (zh) 1995-09-21

Family

ID=26792027

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109442A TW257678B (zh) 1992-11-10 1993-11-10

Country Status (18)

Country Link
EP (2) EP0669827B1 (zh)
JP (1) JPH08506322A (zh)
CN (1) CN1093904A (zh)
AT (1) ATE201327T1 (zh)
AU (2) AU686581B2 (zh)
CA (1) CA2149116A1 (zh)
DE (2) DE69330252T2 (zh)
FI (1) FI952267A (zh)
HR (1) HRP931389A2 (zh)
HU (1) HUT70945A (zh)
IL (1) IL107563A (zh)
NO (1) NO951822L (zh)
NZ (1) NZ258367A (zh)
PL (1) PL309001A1 (zh)
SI (1) SI9300586A (zh)
TW (1) TW257678B (zh)
WO (1) WO1994011006A1 (zh)
YU (1) YU71393A (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
EP0669827B1 (en) * 1992-11-10 2001-05-23 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
AU2002243630A1 (en) 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
US7285536B2 (en) 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
ITMI20021294A1 (it) * 2002-06-12 2003-12-12 Inalco Spa Polisaccaridi batterici o-solfatati e loro uso
EP1731131A1 (en) * 2004-03-29 2006-12-13 Kringle Pharma Inc. Hgf production accelerator containing heparin-like oligosaccharide
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione
IN2014CN02468A (zh) 2011-09-08 2015-06-19 Novozymes Bioag As
US9055746B2 (en) * 2011-09-23 2015-06-16 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
CN102824352B (zh) * 2011-10-11 2013-09-04 泸州医学院 一种双糖化合物在制备抗肿瘤药物中的用途
CN109730006B (zh) * 2019-03-19 2022-10-18 西华大学 提高动物黑色素含量的方法
CN110646557A (zh) * 2019-10-12 2020-01-03 北京航空航天大学 携带idh基因突变的胶质母细胞瘤患者的尿液代谢标志物及其用途
KR20220159397A (ko) 2020-03-12 2022-12-02 시드니 데이비드 컬리스-힐 코로나바이러스 감염 및 관련 사이토카인 독성용 치료

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2538404B1 (zh) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
JPH0818993B2 (ja) * 1989-11-28 1996-02-28 キッセイ薬品工業株式会社 プロスタグランジンｉ▲下２▼産生増強剤
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
CA2102207A1 (en) * 1991-05-02 1992-11-03 Irun R. Cohen Compositions for the prevention and/or treatment of patholigical processes
EP0669827B1 (en) * 1992-11-10 2001-05-23 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity

Also Published As

Publication number Publication date
AU699624B2 (en) 1998-12-10
FI952267A (fi) 1995-07-10
PL309001A1 (en) 1995-09-18
HUT70945A (en) 1995-11-28
ATE201327T1 (de) 2001-06-15
CA2149116A1 (en) 1994-05-26
FI952267A0 (fi) 1995-05-10
NO951822L (no) 1995-06-29
CN1093904A (zh) 1994-10-26
NO951822D0 (no) 1995-05-09
IL107563A0 (en) 1994-02-27
DE69334102D1 (de) 2007-02-22
HRP931389A2 (en) 1995-04-30
SI9300586A (en) 1994-09-30
NZ258367A (en) 1997-02-24
EP0669827A1 (en) 1995-09-06
JPH08506322A (ja) 1996-07-09
AU686581B2 (en) 1998-02-12
IL107563A (en) 2006-12-31
YU71393A (sh) 1997-05-28
AU6478398A (en) 1998-06-25
EP0669827A4 (en) 1996-08-28
DE69330252D1 (de) 2001-06-28
AU5599394A (en) 1994-06-08
EP0669827B1 (en) 2001-05-23
HU9501373D0 (en) 1995-06-28
DE69334102T2 (de) 2007-10-18
EP1095657A2 (en) 2001-05-02
DE69330252T2 (de) 2002-02-07
EP1095657B1 (en) 2007-01-10
WO1994011006A1 (en) 1994-05-26
EP1095657A3 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
TW257678B (zh)
CA2118121C (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
EP0876143A4 (en) TUMORNROSE FACTOR ALPHA (TNF-ALPHA) INHIBITING MEDICINAL PRODUCTS
SG49625A1 (en) Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
AU1639497A (en) Methods for preventing or inhibiting bone loss with 3,4-diarylchroman
AU5046693A (en) Use of purified surface modifiers to prevent particle aggregation during sterilization
AU3876295A (en) Hypolipidemic benzothiazepines
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
AU4319493A (en) Indolocarbazole imides and their use
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
CA2020346A1 (en) Antibiotic ge 2270 factors a1, a2, a3 and h
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
DE3786682T2 (de) ACTH-Fragmente enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Schockzuständen sowie von respiratorischen und Herz-Kreislauf-Insuffizienzen.
RU95113594A (ru) Композиции для регулирования активности цитокина
Burger et al. Low early mortality of allogeneic bone marrow transplantation by use of fractionated total body irradiation, Cyclosporin-A, long lasting LAF-isolation and gut decontamination
Roekke et al. Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with imipenem or cefuroxime/metronidazole
WO1994008474A3 (en) Medical food and method of administration
RU93054957A (ru) Способ получения растительного биологически активного полисахарида
IT9021051A0 (it) "procedimento di estrzione e purificazione del gamma interferone umano ricombite"
CA2268525A1 (en) The use of growth hormone as an aid for hypothermia